Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Acta Obstet Gynecol Scand. 2020 Apr 9;99(9):1181–1190. doi: 10.1111/aogs.13846

TABLE 3.

Cut-off at 32 weeks. Crude results. Differences between early onset preeclampsia (EOP) and late onset preeclampsia (LOP): EOP, n = 466 (26.8%); LOP: n = 1270 (73.2%). Multiparae with preeclampsia: EOP, n = 255 (28.4%); LOP, ∣n = 644 (71.6%)

Nonsignificant results
Left numbers EOP, n = 466
Right numbers LOP, n = 1270
P value Significant results
EOP vs LOP
ODDS ratios [95% CI]
Underlined: difference with cut-off 34 weeks
P value
Gestation (mean,SD) 2.9 vs 2.75 .18 Mother’s age (y,SD) 29.7 vs 28.6 .002
Parity (mean, SD 1.30 vs 1.17 .14 Chronic hypertension 12.9% vs 9.3% 1.44 [1.04-2.0] .02
Primiparity 45.3% vs 49.3% OR 0.85 .14 Gestational diabetes 12.1% vs 15.9% 0.73 [0.53-1.01] .06
Adolescents (<18 y) 2.6% vs 3.7% OR 0.69 .25 Antecedent perinatal deaths 13.9% vs 9.7% 1.49 [1.0-2.2] .05
Grand multiparae (5+) 11.2% vs 9.5% OR 1.2 .29 Antecedent preeclampsia 14.5% vs 7.5% 2.07 [1.4-3.0] .0001
Single mother 36.1% vs 37.7% OR 0.93 .53
Years of schooling ≥10 55.3% vs 55.4% OR 1.0 .97
BMI ≥25 kg/m2 55.2% vs 53.1% OR 1.09 .47
BMI ≥30 kg/m2 28.6% vs 29.3% OR 0.97 .79
Preexisting diabetes 4.3% vs 4.4% OR 0.99 .96
Smoking 9.9% vs 8.6% OR 1.12 .40
Antecedent miscarriage 312% vs 30.7% OR 1.03 .85
Antecedent abortion 27.4% vs 23.1% OR 1.26 .12
Antecedent thyroid diseasea 1.5% vs 1.3% OR 1.12 .79
Antecedent renal disease 1.7% vs 0.9% OR 1.99 .20
Medically induced 2.1% vs 1.5% OR 1.4 .34
Allergy/asthma 7.1% vs 7.1% OR 0.99 .49
Differences from cut-off at 34 weeks’ gestation
Items becoming NON significant Items becoming SIGNIFICANT
Primigravidity 32.0% vs 36.3% OR 0.82 .09 Coagulopathyb 1.3% vs 0.5% OR 2.7 .07
Pre-pregnancy/booking BMI 26.7 vs 26.9 kg/M2 .60 35 y+ 27.5% vs 23.5% OR 1.23 .09
a

Thyroid diseases: goiter, hypo/hyperthyroidism, thyroidectomy, thyroid node, thyroiditis.

b

“Coagulopathies”: antiphospholipid syndrome, protein C/protein S deficit, factor 5, Leyden or other coagulation factors.